Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Study: Depression Drug May Aid Weight
July 11, 2002

LEXINGTON, Ky. (AP) -- A drug used to quit smoking and treat depression helps obese people lose weight and keep it off, researchers report.

The drug, bupropion SR, is sold as Wellbutrin for depression and Zyban for nicotine addiction. In a yearlong study, it was shown to help reduce weight and keep it off when combined with diet and exercise, said Dr. James Anderson, professor of medicine and clinical nutrition at the University of Kentucky's College of Medicine.

About 51 million Americans are obese and another 61 million are overweight, according to the American Obesity Association.

"Obesity is a huge problem, especially among children, and the treatments we offer aren't very effective," Anderson said Tuesday.

"There are no magic bullets for treating obesity. Diet and exercise are still the keys to long-term weight loss. But this does give us another arrow in the quiver in helping to treat it."

The study, reported in July's Obesity Research, was paid for by the drug's manufacturer, GlaxoSmithKline.

During the first half of the 48-week study, 227 obese people were randomly assigned to take one of two doses of bupropion or a dummy pill each day. Participants also were on a restricted diet and asked to increase their exercise by about 50 percent.

Those on the higher dose of bupropion lost 10 percent of their body weight compared with 7 percent for those on the lower dosage. Those who took the dummy pill lost about 5 percent of their body weight.

In the second 24 weeks, 192 participants who completed the first part of the study were all given bupropion and were able to sustain their weight loss.

Those on the higher dose maintained an 8.6 percent loss and those on the lower dose maintained a 7.5 percent loss.

"This is a drug that people have taken for many years to treat depression with few problems or side effects," said Dr. Richard Atkinson, president of the American Obesity Association. "If it can be just as effective in treating obesity, it has the potential to help a lot of people."

Anderson said the drug, which has limited side effects like dry mouth and diarrhea, reduces the flow of behavioral hormones norepinephrine and dopamine to the brain, helping to reduce the urge to eat.

Copyright 2002 The Associated Press. All rights reserved.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001